Código QR

Surrogate Endpoints in Pivotal Clinical Trials for Drug Approval in Japan Compared to the United States

ABSTRACT Regulatory guidance documents exist on surrogate endpoints in the United States. In Japan, there are no established rules or guidance regarding the use of surrogate endpoints, and various aspects remain unclear. The aim of this study was to investigate the use of surrogate endpoints in Japa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Yuko Yamamoto, Harumi Kosaka, Hanami Nojiri, Hideki Maeda
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2025-11-01
Colecção:Clinical and Translational Science
Assuntos:
Acesso em linha:https://doi.org/10.1111/cts.70413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!